Molinar (Colecalciferol)

Colecalciferol, the active ingredient in Molinar, is a Vitamin D presented as an oral supplement for oral use. It is used to address vitamin D deficiency and supports calcium and phosphate balance in individuals with low serum levels. The supplement is formulated for easy administration and is available without prescription in the European market.

GNH USA supplies Molinar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Molinar, a vitamin D supplement, is used to correct deficiencies in the vitamin D metabolic pathway.

- Vitamin D deficiency: restores normal serum 25‑hydroxyvitamin D levels and supports calcium homeostasis. - Osteomalacia: improves bone mineralization and reduces bone pain associated with softening. - Rickets in children: aids in proper bone growth and prevents skeletal deformities.

Colecalciferol may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: occasional stomach upset after ingestion. - Constipation: intermittent difficulty with bowel movements. - Hypercalcemia symptoms: mild fatigue or headache. - Dry mouth: transient sensation of oral dryness.

Serious or Rare Side Effects: - Severe hypercalcemia: may present with vomiting, arrhythmia, or renal impairment. - Allergic reaction: rash, itching, or swelling that requires medical attention.

When using Molinar, consider the following precautions to ensure safe and effective therapy.

- Pregnancy and lactation: safety has not been established; use only if clearly needed. - Renal disease: monitor serum calcium and vitamin D levels closely. - Hyperparathyroidism: avoid excess dosing to prevent hypercalcemia. - Sarcoidosis or granulomatous disease: increased risk of vitamin D toxicity. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Colecalciferol can affect the activity of several medicines; interactions are classified by clinical significance.

Major Interactions (Avoid): - Thiazide diuretics: may exacerbate hypercalcemia. - Vitamin D analogues (e.g., calcitriol): risk of excessive calcium levels.

Moderate Interactions (Monitor Closely): - Orlistat: reduces absorption of fat‑soluble vitamins, including vitamin D. - Anticonvulsants (e.g., phenytoin, phenobarbital): increase vitamin D metabolism, potentially lowering efficacy. - Corticosteroids: may diminish vitamin D activity, requiring monitoring of serum levels.